Categories AlphaGraphs, Earnings, Industrials
CarMax (KMX) Q2 2026 earnings drop on lower sales, miss estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the second quarter of fiscal 2026, hurt by lower sales.
Net sales and operating revenues decreased to $6.59 billion in the second quarter from $7.01 billion in the comparable quarter of FY25. During the quarter, retail used unit sales and comparable store used unit sales declined by 5.4% and 6.3% respectively. Wholesale units dropped 2.2%.

Second-quarter net income declined to $95.4 million or $0.64 per share from $132.8 million or $0.85 per share in the prior-year quarter, and came in below Wall Street’s estimates.
During the quarter, the company bought 293,000 vehicles from consumers and dealers, which is down 2.4% from the prior-year period. It repurchased $180.0 million of its common shares in Q2.
“While this was a challenging quarter, we remain confident in our long-term strategy and the strength of the earnings model that we have built. We are excited about the recent launch of our new brand positioning campaign `Wanna Drive?’ that brings our differentiated omni-channel experience to life and underscores our ongoing commitment to empowering the customer,” said Bill Nash, chief executive officer of CarMax.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to


